Fig. 1From: An economic evaluation of intensive hypertension control in CKD patients: a cost-effectiveness studyMarkov decision model depicting hypertension control for CKD CKD, chronic kidney disease; SAE, serious adverse event; CVD, cardiovascular disease; HF, heart failure; MI, myocardial infarction. †The Markov node of "Standard" treatment is the same on that of "Intensive" treatmentBack to article page